Disease/Infection News

RSS

Medivir AB announces license agreement with Daewoong Pharmaceutical for MIV-210 drug

Medivir AB (Sweden) today announced a license agreement with Daewoong Pharmaceutical Co. Ltd., (South Korea) for its hepatitis B virus (HBV) polymerase inhibitor drug, lagociclovir valactate (MIV-210).

12 Mar 2010

Children with chronic illness more likely to develop H1N1 influenza: Study

As critical care professionals develop a better understanding of the progression of H1N1, they are becoming better prepared to treat children with severe cases, according to a new study that will be published in the March issue of Pediatric Critical Care Medicine (PCCM).

12 Mar 2010

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Former President Bill Clinton and Bill Gates, co-chair of the Bill & Melinda Gates Foundation, said Wednesday at a Senate Foreign Relations Committee hearing "that U.S. investments in fighting [HIV/]AIDS, malaria and other diseases in underdeveloped nations save lives and play a vital role in improving America's image abroad," the Associated Press reports.

12 Mar 2010

Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval

Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen for Dacogen® (decitabine) for Injection to treat patients with myelodysplastic syndromes (MDS), a group of bone marrow diseases that alter the production of functional blood cells.

12 Mar 2010

Boston Scientific's Express LD Iliac Premounted Stent System for use in iliac arteries receives FDA approval

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac Premounted Stent System for use in iliac arteries. The Express LD Iliac Stent is the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease. The Company said it plans to launch the product immediately in the United States.

12 Mar 2010

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.

12 Mar 2010

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

Baxter International Inc., in conjunction with DynPort Vaccine Company LLC, a CSC Company, today presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter’s Vero cell culture platform and does not contain an adjuvant or preservatives. The data were presented at the International Congress on Infectious Disease (ICID) in Miami, Florida.

From Baxter International Inc. 12 Mar 2010

HTDS receives Registration Certificate for MEVAC-Vari vaccine in Guatemala

Hard to Treat Diseases and its subsidiary Mellow Hope announce that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala.

12 Mar 2010

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

The Human Papillomavirus (HPV) is the causative agent responsible for most cases of cervical cancer, but is also associated with several other types of cancer.

12 Mar 2010

AIDS 2010 to highlight epidemic in Eastern Europe, Central Asia regions

AIDS 2010, the International AIDS Conference to be held July 18-23 in Vienna, Austria, will "highlight the situation in Eastern Europe and Central Asia, regions experiencing fast growing [HIV/AIDS] epidemics largely through unsafe injecting drug use," conference organizers announced Wednesday, Agence France-Presse reports.

11 Mar 2010

Whole genome sequencing of entire family beneficial

The Institute for Systems Biology (ISB) has analyzed the first whole genome sequences of a human family of four. The findings of a project funded through a partnership between ISB and the University of Luxembourg was published online today by Science on its Science Express website. It demonstrates the benefit of sequencing entire families, including lowering error rates, identifying rare genetic variants and identifying disease-linked genes.

11 Mar 2010

Octenol compound aids mosquitoes in finding blood meal

The potentially deadly yellow-fever-transmitting Aedes aegypti mosquito detects the specific chemical structure of a compound called octenol as one way to find a mammalian host for a blood meal, Agricultural Research Service (ARS) scientists report.

11 Mar 2010

WHO issues new guidelines for malaria treatment

The World Health Organization (WHO) is releasing new guidelines for the treatment of malaria, and the first ever guidance on procuring safe and efficacious anti-malarial medicines.

11 Mar 2010

Key stakeholder groups convene to address noncommunicable diseases at Global Forum

The first Global Forum of the Noncommunicable Disease Network (NCDnet) marks the first time WHO has convened key stakeholder groups to address the large-scale and increasing global health and development burden posed by noncommunicable diseases (NCDs).

11 Mar 2010

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

The Senate Finance Committee's chair, Max Baucus (D-Mont.), and top Republican, Charles Grassley (Iowa), are working with colleagues in the House on legislation that would lower tariffs in an effort to help Haiti's apparel industry and help the country recover from the major January earthquake, CQ Politics reports.

11 Mar 2010

WHO's updated malaria guidelines include rapid diagnosis, new ACT

The WHO on Tuesday released new guidelines for the treatment of malaria, which recommend "parasitological testing before treatment begins" and add "a new artemisinin based combination treatment [ACT] to the list of prescribed drugs," BMJ News reports.

11 Mar 2010

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Chronic kidney disease (CKD) afflicts a large number of younger minority adults receiving medical care in settings that serve the uninsured and underinsured (settings collectively known as the healthcare safety net). Poor, minority adults with moderate to severe CKD are also two to four times more likely to progress to kidney failure than non-Hispanic whites.

11 Mar 2010

$TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers$

TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers

OccuLogix, Inc., dba TearLab Corporation, announced today that TLCVision Corporation, North America's premier eye care services company, will be incorporating the TearLab™ Osmolarity System in eight of its U.S. refractive surgery centers to study Dry Eye Disease symptoms as they relate to LASIK surgery.

11 Mar 2010

British government, HIV/AIDS advocates warn decreased aid budgets could lead to reversals in HIV/AIDS treatment progress

Recent gains in the global fight against HIV/AIDS could be reversed as the "global economic downturn pinches poor countries' budgets and donors show signs of backing away from their promise to provide universal access to AIDS treatment," the British government together with Medecins Sans Frontieres warned Tuesday, Reuters AlertNet reports.

11 Mar 2010

FDA sponsoring workshops to increase rare disease treatment options

The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.

11 Mar 2010

Disease/Infection News

Medivir AB announces license agreement with Daewoong Pharmaceutical for MIV-210 drug

Children with chronic illness more likely to develop H1N1 influenza: Study

Former President Clinton, Bill Gates encourage U.S. global health investment at Senate Foreign Relations Committee hearing

Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval

Boston Scientific's Express LD Iliac Premounted Stent System for use in iliac arteries receives FDA approval

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

HTDS receives Registration Certificate for MEVAC-Vari vaccine in Guatemala

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

AIDS 2010 to highlight epidemic in Eastern Europe, Central Asia regions

Whole genome sequencing of entire family beneficial

Octenol compound aids mosquitoes in finding blood meal

WHO issues new guidelines for malaria treatment

Key stakeholder groups convene to address noncommunicable diseases at Global Forum

Congress works on tariff-lowering legislation for Haiti as Preval meets with U.S. leaders in Washington

WHO's updated malaria guidelines include rapid diagnosis, new ACT

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

TLCVision to incorporate TearLab Osmolarity System to study DED in refractive surgery centers

British government, HIV/AIDS advocates warn decreased aid budgets could lead to reversals in HIV/AIDS treatment progress

FDA sponsoring workshops to increase rare disease treatment options

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News